| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/24/2003 | CA2746795A1 Method for crystallizing reduced coenzyme q10 |
| 04/24/2003 | CA2727642A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2466082A1 Anti-microbial composition comprising a metal ion chelating agent |
| 04/24/2003 | CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | CA2463898A1 Methods and materials for targeting and affecting selected cells |
| 04/24/2003 | CA2463711A1 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | CA2463687A1 Cyclodextrin complexes |
| 04/24/2003 | CA2463655A1 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 04/24/2003 | CA2463579A1 Treatment of cns disorders using cns target modulators |
| 04/24/2003 | CA2463473A1 Targeted therapeutic proteins |
| 04/24/2003 | CA2463435A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 04/24/2003 | CA2463020A1 Use of gp130 activators in diabetic neuropathy |
| 04/24/2003 | CA2463017A1 Method for preparation of single chain antibodies |
| 04/24/2003 | CA2463016A1 Composition comprising paracetamol and a bitterness masking component |
| 04/24/2003 | CA2462639A1 Kahalalide compounds for use in cancer therapy |
| 04/24/2003 | CA2462219A1 Pharmaceutical formulation comprising (r) -bicalutamide |
| 04/24/2003 | CA2461575A1 Use of peptide vectors to improve the immune response to antigens |
| 04/24/2003 | CA2461556A1 Compositions and methods for delivery of microparticles of poorly water soluble drugs and methods of treatment |
| 04/24/2003 | CA2461550A1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 04/24/2003 | CA2461542A1 Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| 04/24/2003 | CA2461168A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline |
| 04/24/2003 | CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | CA2460209A1 A method for preparing liposome formulations with a predefined release profile |
| 04/23/2003 | EP1304346A2 Conjugate of polyethylene glycol and chitosan |
| 04/23/2003 | EP1304122A2 Composition and method for enhancing transport across biological membrane |
| 04/23/2003 | EP1304118A2 Therapeutic uses and formulations for BPI protein products. |
| 04/23/2003 | EP1303635A2 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in the therapeutics and/or diagnostics |
| 04/23/2003 | EP1303541A1 Gel compositions containing metronidazole |
| 04/23/2003 | EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 04/23/2003 | EP1303481A1 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 04/23/2003 | EP1303298A2 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 04/23/2003 | EP1303297A2 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency |
| 04/23/2003 | EP1303292A1 Chemokine conjugates |
| 04/23/2003 | EP1303283A2 Treatment of hyperproliferative skin disorders and diseases |
| 04/23/2003 | EP1303278A1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 04/23/2003 | EP1303275A2 Paroxetine tablets and capsules |
| 04/23/2003 | EP1303273A1 New pharmaceutical composition and the process for its preparation |
| 04/23/2003 | EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 04/23/2003 | EP1303267A1 Dermal for amino laevulinic acid |
| 04/23/2003 | EP1303261A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 04/23/2003 | EP1303260A2 Linkage of agents using microparticles |
| 04/23/2003 | EP1303259A1 Prolonged release microspheres for injection delivery and preparation method |
| 04/23/2003 | EP1303258A1 Novel aerosol formulation containing a polar fluorinated molecule |
| 04/23/2003 | EP1303249A1 Antimycotic nail varnish composition |
| 04/23/2003 | EP1250055A4 Immune modulation with death receptor-induced apoptosis |
| 04/23/2003 | EP1242009A4 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 04/23/2003 | EP1146862B1 Pharmaceutical compositions |
| 04/23/2003 | EP1135397B1 Method for preparation of disodium pamidronate |
| 04/23/2003 | EP1131072B1 Pharmaceutical combination preparations in solid dosage form of carvedilol and hydrochlorothiazide |
| 04/23/2003 | EP1131063B1 Hyperforin ointment or cream |
| 04/23/2003 | EP1121102B1 Liposome-entrapped topoisomerase inhibitors |
| 04/23/2003 | EP1105109B1 Injectable formulations of nanoparticulate naproxen |
| 04/23/2003 | EP1047406B1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 04/23/2003 | EP1030689B1 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| 04/23/2003 | EP1017363B1 Taste masking for unpalatable formulations |
| 04/23/2003 | EP0941085B1 Device for electrically assisted delivery of agents such as lidocaine and epinephrine |
| 04/23/2003 | EP0910412B1 Hydrolysable hydrogels for controlled release |
| 04/23/2003 | EP0881915B1 Improvements in or relating to contrast agents |
| 04/23/2003 | EP0871691B1 Process for purifying alkoxylated fats |
| 04/23/2003 | EP0863762A4 Methods of production and use of liquid formulations of plasma proteins |
| 04/23/2003 | EP0859599B1 Liposomal formulations of mitoxantrone |
| 04/23/2003 | EP0831825B1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 04/23/2003 | EP0797443B1 A pharmaceutical composition with improved bio-availability of inositol phosphate |
| 04/23/2003 | EP0795128B1 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents |
| 04/23/2003 | EP0788373B1 Novel complexes of taxol or taxotere and pharmaceutical compositions |
| 04/23/2003 | CN1413241A Dry compositions containing hydrophobic amino acid |
| 04/23/2003 | CN1413120A Method of inactivating pathogens |
| 04/23/2003 | CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 04/23/2003 | CN1413114A System for stabilizing lacrimal fluid layer |
| 04/23/2003 | CN1413110A Pharmaceutical composition |
| 04/23/2003 | CN1411870A Acupoint plaster and its application |
| 04/23/2003 | CN1411825A Medicine for curing burn and scald and its production method |
| 04/23/2003 | CN1411812A Oral medicine preparation with high absorbency |
| 04/23/2003 | CN1411805A Biological medicine film and its preparation method |
| 04/23/2003 | CN1411804A Film forming composition containing sucralose |
| 04/23/2003 | CN1106380C New synthetic catechol derivatives, method for production and use thereof |
| 04/23/2003 | CN1106194C 组合物 The composition |
| 04/23/2003 | CN1106192C Oil in water emulsions containing 2,6,-diisopropyl phenic and ehtylenedinamine-tetraacetic salt |
| 04/23/2003 | CN1106191C Methyl-naphthyl-oxythiophene-propyl amine enteric pellets |
| 04/22/2003 | US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating |
| 04/22/2003 | US6552170 Derivatives of polyethylene glycol and related hydrophilic polymers and to polypeptides that have been covalently bonded to such active derivatives |
| 04/22/2003 | US6552166 Process for the preparation of conjugates useful in the treatment of prostate cancer |
| 04/22/2003 | US6552146 Composition comprising polymers having a star structure, the polymers, and their use |
| 04/22/2003 | US6552142 Free-radical polymerization of ethylenically unsaturated monomers in an aqueous medium comprising hydrophilic monomer A which has and N-vinyl group and monoethylenically unsaturated hydrophobic monomer and free-radical initiator |
| 04/22/2003 | US6552082 Solubility makes it possible to manufacture a solution of higher concentration of the compound and high-dosage drug product |
| 04/22/2003 | US6552024 For administering agents in a dissolving film configuration; drug delivery |
| 04/22/2003 | US6552007 A conjugate of somatostatin analog-spacer-anticarcinogenic agent increases the specificity on targeted tumor cells, thus reducing side effects; drug delivery; e.g., octreotide-CO-CH2-CH2-(O-CH2-CH2)(1-7)-CO-paclitaxel |
| 04/22/2003 | US6552004 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 04/22/2003 | US6552002 Miticides, parasiticides; veterinary medicine |
| 04/22/2003 | US6551992 Stable insulin formulations |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551626 Composition containing pyrrolizidine-alkaloid-free petasites |
| 04/22/2003 | US6551622 Storage-stable hydrophilic therapeutic agent is prepared by formulating therapeutic proteins with hydrophobically-derivatised carbohydrates; drug delivery |
| 04/22/2003 | US6551621 A protective coatings for improving drug stability over time; treatment of gastric and duodenal ulcers |
| 04/22/2003 | US6551620 Pellet formulation for the treatment of the intestinal tract |
| 04/22/2003 | US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival |
| 04/22/2003 | US6551617 Taste masking coating composition |
| 04/22/2003 | US6551616 Reducing gastrointestinal adverse side effects and improving taste |
| 04/22/2003 | US6551613 Dosage form comprising therapeutic formulation |
| 04/22/2003 | US6551610 Multifaceted compositions for post-surgical adhesion prevention |